Staburo GmbH

What Staburo GmbH does

Staburo GmbH is a Munich-based biostatistics and clinical data science consulting firm founded in 2008 that delivers expert services to pharmaceutical, biotechnology, CRO, and medical device companies. The firm's offering is organized into three core areas: Clinical Data Science (clinical statistics, statistical programming, data management, and health technology assessment); Biomarkers & Translational Data Science (biomarkers, bioinformatics, diagnostics, and CMC & non-clinical statistics); and Data Transparency & Medical Writing (clinical trial disclosure, data anonymization and document redaction, and medical writing). The portfolio is complemented by Staburo Academy, a client training program. Underlying capability is built on statistical and data science methodologies, bioinformatics, translational medicine, and regulatory expertise, with no proprietary technology platform disclosed; recent methodological R&D includes a peer-reviewed paper on the shadowVIMP variable selection method published in BMC Bioinformatics in May 2026.

The business operates as a B2B professional services firm generating revenue through consulting engagements on a project or retainer basis (pricing not publicly disclosed). Distribution is direct and relationship-based, leveraging the firm's reputation, BVMA industry association membership, and senior-staff access to client decision-makers. The firm offers flexible delivery models spanning full outsourcing to embedded experts integrated into client R&D teams, with an explicit emphasis on long-term partnerships over transactional work. Operations are headquartered at Aschauer Straße 26a, D-81549 München, and the firm is structured as an independent, owner-led private limited company (GmbH) with 11-50 employees and no disclosed external investors, funding rounds, or M&A activity.

Name

Staburo GmbH

Legal name

Staburo GmbH

Website

https://staburo.de

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Staburo GmbH is a Munich-based biostatistics and clinical data science consultancy founded in 2008 that provides statistical analysis, programming, biomarkers, bioinformatics, medical writing, and clinical trial disclosure services to pharmaceutical, biotech, CRO, and medical device companies across all clinical development phases.

Ownership category

akta.pro rank

Product category

Clinical Biostatistics Consulting

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)

akta.pro secondary industries

Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB)

Keywords

• Biostatistics consulting
• Clinical data science
• Statistical programming
• Medical writing services
• Clinical trial disclosure

Headquarters

HQ city

München

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Biostatistics and Data Science Services: Professional services revenue model providing expert biostatistics, data science, statistical programming, medical writing, and data transparency services to pharmaceutical and biotech companies across all phases of clinical development. Revenue is generated through consulting engagements with flexible insourcing and outsourcing models, with experts potentially embedded into client teams.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Staburo GmbH delivers biostatistics, data science, and transparency solutions for pharmaceutical and biotech companies across all phases of clinical development. The firm provides clinical statistics, statistical programming, data management, bioinformatics, biomarker analysis, clinical trial disclosure, data anonymisation, and medical writing services. Engagements are delivered through flexible insourcing and outsourcing models, with experts either embedded in client R&D teams or delivering standalone projects.

Product overview

Staburo GmbH offers a unified portfolio of biostatistics, data science, and transparency solutions for pharmaceutical and biotech companies. The company operates through three interconnected core business areas: Clinical Data Science (clinical statistics, statistical programming, data management, health technology assessment), Biomarkers & Translational Data Science (biomarkers, bioinformatics, diagnostics, CMC & non-clinical statistics), and Data Transparency & Medical Writing (clinical trial disclosure, data anonymisation, medical writing). These services are delivered through flexible insourcing and outsourcing models, with embedded experts supporting client R&D teams. The offering is complemented by Staburo Academy for client training programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Data Science Core service area providing clinical statistics, statistical programming, data management, and health technology assessment for clinical development programs of pharmaceutical and biotech clients.
• Biomarkers & Translational Data Science Specialized service area covering biomarkers, bioinformatics, diagnostics, and CMC & non-clinical statistics to support translational medicine and biomarker-driven research for drug development clients.
• Data Transparency & Medical Writing Service area providing clinical trial disclosure, data anonymisation & document redaction, and medical writing services to ensure regulatory compliance and transparency for clinical research sponsors.
• Staburo Academy Training and education programs for clients covering biostatistics, data science, and clinical research topics, including tailored webinars and courses ranging from 1-hour sessions to 2-day courses.
• Expertise & Solutions Flexible insourcing and outsourcing service delivery models providing embedded experts, with senior expertise and regulatory-compliant processes across therapeutic areas for clinical research clients.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• BVMA (Bundesverband Medizinischer Auftragsinstitute)minorOthersMembership in the German industry association for medical research organizations. Indicates compliance with professional standards and industry participation rather than a strategic commercial partnership.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Cytel: Cytel is the leading pure-play biostatistics and statistical programming CRO, offering clinical statistics, adaptive trial design, statistical programming, and real-world evidence — directly comparable to Staburo's core offering, with a similar specialist positioning but at significantly larger scale.
• Quanticate: Quanticate is a specialist biostatistics, statistical programming, and clinical data management CRO serving pharma and biotech — a direct specialist peer to Staburo with overlapping service lines in biometrics and FSP delivery.
• IDDI: IDDI is a Belgian-headquartered biostatistics and clinical data management specialist serving biotech and pharma — closely comparable to Staburo in scope (statistics, data management, regulatory support) and customer base.
• Veristat: Veristat is a clinical research organization focused on biostatistics, statistical programming, clinical data management, and medical writing for oncology and rare disease — a direct specialist peer with overlapping therapeutic area exposure.
• MMS Holdings: MMS is a clinical data science CRO offering biostatistics, statistical programming, regulatory affairs, and medical writing services to pharma and biotech — directly comparable to Staburo's three core business areas.
• Theorem Clinical Research: Theorem provides biostatistics, statistical programming, data management, and medical writing as a specialist CRO — overlapping service lines and customer profile with Staburo.
• Apex Biostatistics: Apex Biostatistics is a niche biostatistics consultancy providing statistical analysis, programming, and clinical trial design services to pharma and biotech — a smaller-scale direct peer with similar specialist positioning.

Broad incumbents

• ICON plc: ICON is one of the world's largest CROs providing full-service clinical development including biostatistics and statistical programming — competes with Staburo on biostatistics capacity but within a much broader integrated offering.
• Parexel: Parexel is a global full-service CRO with substantial biostatistics, statistical programming, and medical writing capabilities — a broad incumbent that competes with Staburo on specialist biometrics work but with much larger scale and bundled services.
• IQVIA: IQVIA is the largest global CRO with extensive biostatistics, data science, and technology-enabled clinical research capabilities — sets the competitive ceiling for specialist players like Staburo, particularly on large multi-asset programs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/staburo-gmbh
• Xx.com/staburo

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Staburo GmbH